Preclinical services for biopharmaceutical product development
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N93023D00011
- Awardee
-
Allucent Government Services (Us) LLC UEI C7DJDL6EZT94
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- Preclinical services for biopharmaceutical product development Pre-Solicitation · 75N93022R00004 · Posted Nov 10, 2021
- Last date to order 44% complete
- IDV ceiling
- $30,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Funding agency
- Office of Logisitics and Acquisition Operations National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 9 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases awarded a single-award indefinite-delivery contract to Allucent Government Services (Us) LLC on September 8, 2023, with a ceiling of $30 million and an ultimate completion date of September 7, 2030.
The contract covers preclinical services supporting biopharmaceutical product development for infectious diseases across five task areas: product development planning and evaluation, analytical assay development and product characterization, process development and related activities, current good manufacturing practice (CGMP) manufacture and related activities, and regulatory activities and documentation. Work is performed under NAICS 541711 and PSC D399.
The originating solicitation, posted November 10, 2021, contemplated multiple awards over a seven-year ordering period. Evaluation criteria included prior similar work, staff qualifications, facilities and resources, safety plans, and experience with technology transfer, preclinical plans, and handling biological agents. The contract carries no set-aside designation and no minimum guarantee is stated.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N93023D00011?
75N93023D00011 was awarded to Allucent Government Services (Us) LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 8, 2023.
How much is contract 75N93023D00011 worth?
75N93023D00011's own ceiling is $30,000,000.
Which agency awarded contract 75N93023D00011?
National Institute of Allergy and Infectious Diseases (National Institutes of Health) awarded 75N93023D00011, with funding from Office of Logisitics and Acquisition Operations (National Institutes of Health).
Who can order from contract 75N93023D00011?
75N93023D00011 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N93023D00011 competed?
The extent of competition for 75N93023D00011 was full and open competition. The government received 9 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV